// App-Quantinova.ai

138 : Applicability of use of sodium- glucose co-transporter-2 inhibitors (SGLT2i) in patients with heart failure with reduced ejection fraction (HFrEF) at London northwest university heathcare NHS trust

Researchers

Presenter

  • Oltiana Lakra

Principal Investigators

  • ANGELICA SHARMA

  • Zahraa Al-Dulaimi

  • Jaskaran Sethi

  • Elaine Hui

  • Jaymin S Shah

Medical Centers

  • London North West Healthcare NHS Trust, London, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Endocrine/metabolic Diseases (ME)

  • Genetic Disorder

Disease

  • Heart failure with reduced ejection fraction

  • Type 1 diabetes mellitus

  • Type 2 diabetes mellitus

  • Congestive heart failure

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • EF-40

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved